The state that led the push to stop OTC sales of pseudoephedrine drugs during the methamphetamine crisis in the US is considering eliminating its Rx requirement while the second state to impose the restriction for all drugs containing the decongestant ingredient has eliminated it.
Oregon was the first and Mississippi the second state to make prescription-only the sales of all pseudoephedrine (PSE)-containing drugs within the state